PMID- 32528054 OWN - NLM STAT- MEDLINE DCOM- 20201130 LR - 20231103 IS - 2045-2322 (Electronic) IS - 2045-2322 (Linking) VI - 10 IP - 1 DP - 2020 Jun 11 TI - Comparison of lung microbiota between antineutrophil cytoplasmic antibody-associated vasculitis and sarcoidosis. PG - 9466 LID - 10.1038/s41598-020-66178-4 [doi] LID - 9466 AB - Microbial involvement in the pathogenesis have been suggested in both antineutrophil cytoplasmic antibody-associated vasculitis (AAV) and sarcoidosis, both of which have lung involvement. However, exhaustive research to assess the bacteria in the lung in AAV and in sarcoidosis have not been performed. We sought to elucidate the distinct dysbiotic lung microbiota between AAV and sarcoidosis. We used 16S rRNA gene high-throughput sequencing to obtain the bacterial community composition of bronchoalveolar lavage fluid (BALF) in patients with AAV (n = 16) compared to patients with sarcoidosis (n = 21). The patients had not undergone therapy with immunosuppressive medication when their BALF was acquired. No difference was observed in alpha-diversity between patients with AAV and patients with sarcoidosis when using all the detected taxa. We defined the taxa of the oral cavity by using the data of oral microbiota of healthy individuals from the Human Microbiome Project (HMP). The analysis using only oral taxa made the difference in alpha-diversity between AAV and sarcoidosis clearer compared with those using all the detected taxa. Besides, the analysis using detected taxa except for oral taxa also made the difference in alpha-diversity between AAV and sarcoidosis clearer compared with those using all the detected taxa. A linear negative relationship between the alpha-diversity and Birmingham vasculitis activity score (BVAS) was detected in the AAV group. The observed p-value for the effect of the disease groups on the ss-diversity was small while the effect of other factors including sex and smoking status did not have small p-values. By excluding oral taxa from all the detected taxa, we found a cluster mainly consisted of sarcoidosis patients which was characterized with microbial community monopolized by Erythrobacteraceae family. Our results suggested the importance of considering the influence of oral microbiota in evaluating lung microbiota. FAU - Fukui, Shoichi AU - Fukui S AUID- ORCID: 0000-0001-5487-4692 AD - Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan. AD - Department of Community Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan. FAU - Morimoto, Shimpei AU - Morimoto S AUID- ORCID: 0000-0002-5340-6851 AD - Innovation Platform & Office for Precision Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan. FAU - Ichinose, Kunihiro AU - Ichinose K AUID- ORCID: 0000-0001-8794-7106 AD - Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan. kichinos@nagasaki-u.ac.jp. FAU - Nakashima, Shota AU - Nakashima S AD - Department of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan. FAU - Ishimoto, Hiroshi AU - Ishimoto H AD - Department of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan. FAU - Hara, Atsuko AU - Hara A AD - Department of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan. FAU - Kakugawa, Tomoyuki AU - Kakugawa T AD - Department of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan. FAU - Sakamoto, Noriho AU - Sakamoto N AUID- ORCID: 0000-0002-7577-476X AD - Department of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan. FAU - Tsuji, Yoshika AU - Tsuji Y AD - Rheumatic and Collagen Disease Center, Sasebo Chuo Hospital, Sasebo, Japan. FAU - Aramaki, Toshiyuki AU - Aramaki T AD - Rheumatic and Collagen Disease Center, Sasebo Chuo Hospital, Sasebo, Japan. FAU - Koga, Tomohiro AU - Koga T AD - Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan. AD - Center for Bioinformatics and Molecular Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan. FAU - Kawashiri, Shin-Ya AU - Kawashiri SY AD - Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan. AD - Department of Community Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan. FAU - Iwamoto, Naoki AU - Iwamoto N AD - Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan. FAU - Tamai, Mami AU - Tamai M AUID- ORCID: 0000-0002-2429-7553 AD - Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan. FAU - Nakamura, Hideki AU - Nakamura H AD - Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan. FAU - Origuchi, Tomoki AU - Origuchi T AD - Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan. AD - Department of Rehabilitation Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan. FAU - Ueki, Yukitaka AU - Ueki Y AD - Rheumatic and Collagen Disease Center, Sasebo Chuo Hospital, Sasebo, Japan. FAU - Suzuki, Shino AU - Suzuki S AD - Kochi Institute for Core Sample Research, X-star, Japan Agency for Marine-Earth Science and Technology (JAMSTEC), Nankoku, Japan. FAU - Mukae, Hiroshi AU - Mukae H AD - Department of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan. FAU - Kawakami, Atsushi AU - Kawakami A AD - Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20200611 PL - England TA - Sci Rep JT - Scientific reports JID - 101563288 RN - 0 (Antibodies, Antineutrophil Cytoplasmic) RN - 0 (RNA, Ribosomal, 16S) SB - IM MH - Aged MH - Aged, 80 and over MH - Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis/immunology/*microbiology MH - Antibodies, Antineutrophil Cytoplasmic/*immunology MH - Bacteria/genetics/*immunology MH - Bronchoalveolar Lavage Fluid/immunology/microbiology MH - Female MH - Humans MH - Lung/*immunology/*microbiology MH - Male MH - Microbiota/genetics/*immunology MH - Middle Aged MH - RNA, Ribosomal, 16S/genetics MH - Sarcoidosis/immunology/*microbiology PMC - PMC7289840 COIS- The authors declare no competing interests. EDAT- 2020/06/13 06:00 MHDA- 2020/12/01 06:00 PMCR- 2020/06/11 CRDT- 2020/06/13 06:00 PHST- 2018/12/16 00:00 [received] PHST- 2020/05/14 00:00 [accepted] PHST- 2020/06/13 06:00 [entrez] PHST- 2020/06/13 06:00 [pubmed] PHST- 2020/12/01 06:00 [medline] PHST- 2020/06/11 00:00 [pmc-release] AID - 10.1038/s41598-020-66178-4 [pii] AID - 66178 [pii] AID - 10.1038/s41598-020-66178-4 [doi] PST - epublish SO - Sci Rep. 2020 Jun 11;10(1):9466. doi: 10.1038/s41598-020-66178-4.